Citation Impact
Citing Papers
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
2013 StandoutScience
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy
2015 StandoutScience
Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa
2010 Standout
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
2007 Standout
Mucosal healing in inflammatory bowel diseases: a systematic review
2012 Standout
Bile in the oesophagus: clinical relevance and ambulatory detection.
1997
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
The Bacterial Fermentation Product Butyrate Influences Epithelial Signaling via Reactive Oxygen Species-Mediated Changes in Cullin-1 Neddylation
2009
Susceptibility of Helicobacter pylori to Levofloxacin and Rifampicin in Israel
2015
The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism
2013 Standout
“Rescue” regimens after Helicobacter pylori treatment failure
2008
Oral butyrate for mildly to moderately active Crohn's disease
2005
Gastrointestinal dysfunction in Parkinson's disease
2003 Standout
Functional Gastroduodenal Disorders
2006 Standout
Indocyanine Green Retention Test as a Noninvasive Marker of Portal Hypertension and Esophageal Varices in Compensated Liver Cirrhosis
2013
Review article: the role of butyrate on colonic function
2007 Standout
Rheumatoid arthritis
2016 Standout
Helicobacter Pylori First-Line and Rescue Treatments in the Presence of Penicillin Allergy
2014
Clinical trial: levofloxacin‐based quadruple therapy was inferior to traditional quadruple therapy in the treatment of resistant Helicobacter pylori infection
2007
AGA technical review: Evaluation of dyspepsia
1998
Importance of mucosal healing in ulcerative colitis
2009
Ulcerative Colitis
2011 Standout
The gut microbiota, bacterial metabolites and colorectal cancer
2014 Standout
Resistance ofHelicobacter pylorito antibiotics from 2000 to 2009 in Shanghai
2010
Dyspepsia and Health Care Seeking in a Community (How Important Are Psychological Factors?)
1998
Attempts to enhance the eradication rate ofHelicobacter pyloriinfection
2014
Activation of Gpr109a, Receptor for Niacin and the Commensal Metabolite Butyrate, Suppresses Colonic Inflammation and Carcinogenesis
2014 Standout
Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis
2014 Standout
Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics
2017 Standout
The abundance and variety of carbohydrate-active enzymes in the human gut microbiota
2013 Standout
Levofloxacin-Based Triple Therapy versus Bismuth-Based Quadruple Therapy for Persistent Helicobacter pylori Infection: A Meta-Analysis. CME
2006
Kyoto global consensus report onHelicobacter pylorigastritis
2015 Standout
Third-Line Rescue Therapy with Bismuth-Containing Quadruple Regimen After Failure of Two Treatments (with Clarithromycin and Levofloxacin) for H. pylori Infection
2013
Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis
2017 Standout
A new oral formulation for the release of sodium butyrate in the ileo-cecal region and colon
2007
Measurement of Spleen Stiffness to Evaluate Portal Hypertension and the Presence of Esophageal Varices in Patients With HCV-Related Cirrhosis
2012
Interaction between microbiota and immunity in health and disease
2020 Standout
Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism
2016 Standout
Role of the gut microbiota in immunity and inflammatory disease
2013 Standout
Levofloxacin- versus metronidazole-based rescue therapy for infection in Japan
2005
Advantages of Moxifloxacin and Levofloxacin-based triple therapy for second-line treatments of persistent Helicobacter pylori infection: a meta analysis
2010
Portal hypertensive bleeding in cirrhosis
2016 Standout
Predominant Symptoms Identify Different Subgroups in Functional Dyspepsia
1999
The Functional Gastrointestinal Disorders and the Rome III Process
2006 Standout
Reassessment of the Diagnostic Value of Histology in Patients with GERD, Using Multiple Biopsy Sites and an Appropriate Control Group
2005
Levofloxacin-based triple therapy for Helicobacter pylori re-treatment: Role of bacterial resistance
2007
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Liver Volume as a Predictor of Functional Improvement Post-DAA Treatment
2017
Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: A prospective study
2014
Helicobacter pylori eradication: Novel therapy for immune thrombocytopenic purpura? A review of the literature
2005
Management of Varices and Variceal Hemorrhage in Cirrhosis
2010
Acid Suppression and Chemoprevention in Barrett’s Oesophagus
2004
Helicobacter pylori and Extragastric Diseases – Other Helicobacters
2005
Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma
1999 Standout
Systematic review and meta‐analysis: levofloxacin‐based rescue regimens after Helicobacter pylori treatment failure
2005
A Liver Stiffness Measurement-Based, Noninvasive Prediction Model for High-Risk Esophageal Varices in B-Viral Liver Cirrhosis
2010
Prokinetics in Patients with Gastroparesis: A Systematic Analysis
1999
Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions
2018 Standout
The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based Consensus
2006 Standout
Rabeprazole: the role of proton pump inhibitors inHelicobacter pylorieradication
2005
Helicobacter pylori: perspectives and time trends
2014
Intestinal epithelial cells: regulators of barrier function and immune homeostasis
2014 Standout
H pylori antibiotic resistance: prevalence, importance, and advances in testing
2004 Standout
Efficacy of levofloxacin-based rescue therapy for Helicobacter pylori infection after standard triple therapy: a randomized controlled trial
2009
Intestinal Commensal Microbes as Immune Modulators
2012
Treatment of functional dyspepsia
2005
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis
2013 Standout
Effect of butyrate enemas on inflammation and antioxidant status in the colonic mucosa of patients with ulcerative colitis in remission
2010
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology
2022 Standout
Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices
2006
Influence of cure of Helicobacter pylori infection on gastric acidity and gastroesophageal reflux: study by 24-h pH monitoring in patients with gastric or duodenal ulcer
2005
Ranitidine Bismuth Citrate Can Help to Overcome Helicobacter pylori Resistance to Clarithromycin In Vivo
2000
Proton pump inhibitors: update on their role in acid-related gastrointestinal diseases
2005
Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases
2019 Standout
Third‐line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures
2006
Measurement of Spleen Stiffness by Acoustic Radiation Force Impulse Imaging Identifies Cirrhotic Patients With Esophageal Varices
2012
Empirical rescue therapy after Helicobacter pylori treatment failure: a 10‐year single‐centre study of 500 patients
2007
Helicobacter pylori first-line treatment and rescue option containing levofloxacin in patients allergic to penicillin
2009
The butyrate story: old wine in new bottles?
2004
Peptic ulcer disease
2009
Dietary supplementation with β-glucan enriched oat bran increases faecal concentration of carboxylic acids in healthy subjects
2007
Essential Role of the JAK/STAT1 Signaling Pathway in the Expression of Inducible Nitric-oxide Synthase in Intestinal Epithelial Cells and Its Regulation by Butyrate
2007
Helicobacter pylori first‐line treatment and rescue options in patients allergic to penicillin
2005
Microbes in Gastrointestinal Health and Disease
2008
Duodenal Helicobacter pylori infection differs in cagA genotype between asymptomatic subjects and patients with duodenal ulcers
1999
Levofloxacin/amoxicillin-based schemesvsquadruple therapy forHelicobacter pylorieradication in second-line
2012
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report
2006 Standout
Predicting Endoscopic Diagnosis in the Dyspeptic Patient: The Value of Predictive Score Models
1997
Interactions between Intestinal Microbiota and Host Immune Response in Inflammatory Bowel Disease
2017
Elastography, Spleen Size, and Platelet Count Identify Portal Hypertension in Patients With Compensated Cirrhosis
2012
Butyrate production from oligofructose fermentation by the human faecal flora: what is the contribution of extracellular acetate and lactate?
2006
Gut Microbiota in Health and Disease
2010 Standout
Regulation of Inflammation by Short Chain Fatty Acids
2011
Fourteen-day optimized levofloxacin-based therapy versus classical quadruple therapy for Helicobacter pylori treatment failures: a randomized clinical trial
2015
The Efficacy of Second‐Line Anti‐Helicobacter pylori Therapy Using an Extended 14‐Day Levofloxacin/Amoxicillin/Proton‐Pump Inhibitor Treatment – A Pilot Study
2012
Regulatory T Cells and Human Disease
2020 StandoutNobel
American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis
2004
Helicobacter pyloriDetection and Antimicrobial Susceptibility Testing
2007
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Skin Health from the Inside Out
2020
Introduction to the human gut microbiota
2017 Standout
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
Potential beneficial effects of butyrate in intestinal and extraintestinal diseases
2011
Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments
2010 Standout
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition
2014 Standout
Evaluation of two enzyme immunoassays for detecting Helicobacter pylori in stool specimens of dyspeptic patients after eradication therapy
2005
Second-line levofloxacin-based triple schemes for Helicobacter pylori eradication
2008
Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: The “Anticipate” study
2016
Review article: short chain fatty acids as potential therapeutic agents in human gastrointestinal and inflammatory disorders
2018
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota
2017 Standout
Helicobacter pylori Virulence and Genetic Geography
1999 StandoutScience
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Effects of topical treatment of sodium butyrate and 5-aminosalicylic acid on expression of trefoil factor 3, interleukin 1β, and nuclear factor κB in trinitrobenzene sulphonic acid induced colitis in rats
2006
The Microbiome in Infectious Disease and Inflammation
2012
Diabetic Autonomic Neuropathy
2003 Standout
The impact of antibiotic resistance on the efficacy of three 7‐day regimens against Helicobacter pylori
2000
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Works of C. Mansi being referenced
Comparison of the main oesophageal pathophysiological characteristics between short‐ and long‐segment Barrett's oesophagus
2002
Topical butyrate improves efficacy of 5‐ASA in refractory distal ulcerative colitis: results of a multicentre trial
2003
A new 1‐week therapy for Helicobacter pylori eradication: rani‐ tidine bismuth citrate plus two antibiotics
1997
Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis
2003
A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: A controlled trial
2004
A study of 4‐ and 7‐day triple therapy with rabeprazole, high‐dose levofloxacin and tinidazole rescue treatment for Helicobacter pylori eradication
2005
Application of the platelet count/spleen diameter ratio to rule out the presence of oesophageal varices in patients with cirrhosis: A validation study based on follow-up
2005
Comparable Helicobacter pylori eradication rates obtained with 4- and 7-day rabeprazole-based triple therapy: a preliminary study
2003
Stool antigen assay (HpSA) is less reliable than urea breath test for post‐treatment diagnosis of Helicobacter pylori infection
2002
Patterns of dyspepsia in patients with no clinical evidence of organic diseases
1990
Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis
2000
Small Intestinal Bacterial Overgrowth in Rosacea: Clinical Effectiveness of Its Eradication
2008
Eradication of Helicobacter pylori may reduce disease severity in rheumatoid arthritis
2002
24-hour gastric pH and extent of duodenal gastric metaplasia in Helicobacter pylori-positive patients
1997
Gastrokinetic effects of levosulpiride in dyspeptic patients with diabetic gastroparesis.
1995
Are clinical patterns of dyspepsia a valid guideline for appropriate use of endoscopy? A report on 2253 dyspeptic patients.
1993
Histological and functional recovery in patients with multifocal atrophic gastritis after eradication of Helicobacter pylori infection.
1999
Limitations of continuous 24-h intragastric pH monitoring in the diagnosis of duodenogastric reflux.
1995